Characteristics and In-hospital Outcomes of Female Patients Presenting with ST-Segment-Elevation Myocardial Infarction Without Standard Modifiable Cardiovascular Risk Factors
Garba Rimamskep Shamaki,Chiwoneso Beverley Tinago,Chibuike Charles Agwuegbo,Jaskomal Phagoora,Tamunoinemi Bob-Manuel
DOI: https://doi.org/10.1016/j.cpcardiol.2024.102830
2024-09-04
Abstract:Background: Standard Modifiable Cardiovascular Risk Factors (SMuRF) such as hypertension, diabetes mellitus, hyperlipidemia, and smoking have long been established in the etiology of atherosclerotic disease. We evaluate in-hospital outcomes of female STEMI patients without these risk factors. Methods: The National Inpatient Sample databases (2016 to 2021) were queried to identify STEMI admissions as a principal diagnosis using ICD 10 codes. Patients with a history of coronary artery disease, myocardial infarction, coronary bypass graft, percutaneous coronary intervention, takotsubo cardiomyopathy, cocaine abuse, and spontaneous coronary dissection and males were excluded from our study population. A final study population aged >18 years was divided into cohorts of SMuRF and SMuRF-less based on the presence of ≥1 risk factor. Multivariate logistic regression model adjusting for baseline characteristics and comorbidities. The primary outcome was in-hospital mortality. The secondary outcomes are STEMI-related complications, and the use of mechanical circulatory support devices. Results: 200,980 patients were identified. 187,776 (93.4%) patients were identified as having ≥1 SMuRF, and 13,205 (6.6%) patients were SMuRF-less. Compared to SMuRF patients, SMuRF-less patients are more likely to be white (75.6% vs. 73.1%, p<0.01) and older median age (69 years [IQR: 58-78] vs 67 years [IQR: 57-81], p<0.01). In comparing co-morbidities, SMuRF-less patients were less likely to have heart failure (28.0% vs. 23.4%, p<0.01), atrial fibrillation/flutter (16.1% vs. 14.6%, p=0.03), chronic pulmonary disease (18.9% vs. 9.5%, p<0.01), obesity (20.7% vs. 9.2%, p<0.01) and aortic disease (1.1% vs. 0.6%, p<0.01). They were however more likely to have dementia (6.9% vs. 5.7%, p<0.01). In evaluating outcomes, SMuRF-less patients had higher in-hospital mortality (aOR 3.2 [95% CI, 2.9 - 3.6]; P<0.01), acute heart failure (aOR 1.6 [95% CI, 1.4 - 1.8]; P<0.01), acute kidney injury (aOR 1.8 [95% CI, 1.7 - 2.1]; P<0.01), and Intra-aortic balloon pump (aOR 1.7 [95% CI, 1.5 - 1.9]; P<0.01). Predictors of higher mortality in SMuRF-less patients include chronic liver disease (OR 6.8, CI 2.4-19.4, p<0.01), and Hispanic race (OR 1.62, CI 1.1-2.5, p<0.01). We also found that SMuRF-less patients were less likely to undergo coronary angiography (aOR 0.5 [95% CI, 0.4 - 0.5]; P<0.01) and percutaneous coronary intervention (aOR 0.7 [95% CI, 0.6 - 0.8]; P<0.01). Conclusion: Female SMuRF-less patients presenting with STEMI have worse in-hospital outcomes when compared to patients with ≥1SMuRF.